Let’s upskill patients on atopic dermatitis

  • 3min
  • Jun. 2023
  • Supported by
  • La Roche-Posay
Atopic dermatitis is the most common chronic inflammatory skin disorder.
A low treatment adherence is often observed in patients due to an insufficient disease awareness, the time-consuming skin care routine, the frequency of emollient application or the complexity of the treatment.

Good practices in AD management need to be followed in order to improve the treatment adherence.
Which then results in a lower frequency of flare-ups and improvement of the QOL.

This is why La Roche-Posay developed an infographic on atopic dermatitis, to educate and inform patients even outside the doctor’s practice or pharmacy.

Infography